本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lipella Pharmaceuticals Inc

2.58
+0.17007.05%
盘前2.590.0100+0.39%05:26 EDT
成交量:5.54万
成交额:13.32万
市值:657.59万
市盈率:-0.54
高:2.58
开:2.36
低:2.25
收:2.41
数据加载中...
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

SEC问询函

Form CORRESP - Correspondence
2024/01/26

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/29

重要事件披露

Form 8-K - Current report
2023/11/23

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

SEC问询函

Form CORRESP - Correspondence
2023/11/02

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/10/26

重要事件披露

Form 8-K - Current report
2023/09/11

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/02

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]